More from this Publisher
More from this Publisher
Related Documents
-
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Arthritis Advisory Committee
56 reads -
Notice: Meetings: Cardiovascular and Renal Drugs Advisory Committee
62 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
34 reads -
Notice: Meetings: Cellular, Tissue and Gene Therapies Advisory Committee
97 reads -
Notice: Meetings:
21 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— TEQUIN injection, 10 milligrams
67 reads -
Notice: Meetings: Medical Devices Advisory Committee
38 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
15 reads -
Notice: Meetings: Antiviral Drugs Advisory Committee
49 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— ACIPHEX (rabeprazol sodium)
73 reads -
Notice: Committees; establishment, renewal, termination, etc.: CollaGenex Pharmaceuticals, Inc., approval withdrawn
71 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— PHENERGAN (Promethazine hydrochloride) tablets, 12.5 milligrams and 50 milligrams
88 reads -
Notice: Meetings: Anti-Infective Drugs Advisory Committee
57 reads -
Notice: Meetings: Pulmonary-Allergy Drugs Advisory Committee
98 reads -
Notice: Meetings: Anti-Infective Drugs Advisory Committee et al.
32 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
22 reads -
Notice: Human drugs:
New drug applications— High Chemical Co., et al. approval withdrawn
34 reads -
Notice: Meetings: Medical Devices Advisory Committee
39 reads -
Notice: Meetings:
58 reads -
Notice: Meetings: Medical Devices Advisory Committee
26 reads
Related Documents
Flag this document
2 Pages
